Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Delayed Quote. Delayed  - 05/04 01:29:18 pm
239.2 CHF   -0.54%
05/03 FOUNDATION MEDI : reports 1Q loss
05/03 ROCHE : FDA Greenlights Zika Blood Center Testing
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/28/2016 04/29/2016 05/02/2016 05/03/2016 05/04/2016 Date
247.3(c) 242.5(c) 242.7(c) 240.5(c) 239.2 Last
1 354 333 1 580 049 715 804 1 469 238 335 046 Volume
-0.48% -1.94% +0.08% -0.91% -0.54% Change
More quotes
Financials ( CHF)
Sales 2016 50 933 M
EBIT 2016 18 097 M
Net income 2016 11 566 M
Debt 2016 10 221 M
Yield 2016 3,56%
Sales 2017 53 604 M
EBIT 2017 19 583 M
Net income 2017 12 733 M
Debt 2017 4 697 M
Yield 2017 3,80%
P/E ratio 2016 17,47
P/E ratio 2017 15,81
EV / Sales 2016 4,28x
EV / Sales 2017 3,97x
Capitalization 207 966 M
More Financials
Company
Roche Holding AG operates as a research healthcare company.It operates through the diagnostics and pharmaceuticals segments.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The diagnostic segment... 
Sector
Pharmaceuticals
Calendar
06/06 | 01:30amPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
05/03 FOUNDATION MEDICINE : reports 1Q loss
05/03 FOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Finan..
05/03 ROCHE : FDA Greenlights Zika Blood Center Testing
05/03 ROCHE : Grapevine
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies at 2016 Ame..
05/03 GENENTECH : Highlights Personalized Medicines and Cancer Immunotherapies at 2016..
05/02 ROCHE : CHMP recommends EU approval of Roche's Gazyvaro for people with previous..
05/02 ROCHE : Glycotope names new chief medical officer
More news
Sector news : Pharmaceuticals - NEC
09:03a MERCK AT SID : Materials for the Displays of Today and Tomorrow
08:50aDJJ&J Appeals $127 Million in Awards in Talc Cancer Cases -- WSJ
08:46a ASTRAZENECA : *hsbc cuts astrazeneca price target to 4240 pence - 'hold'
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/02 WisdomTree Dynamic Currency Hedged International Equity Fund (DDWM) April Sum..
05/02 GILEAD : Mistakes Made By Bulls And Bears
04/29 Oncobiologics on deck for IPO
04/29 Roche nabs two positive Ad Comm opinions in Europe for expanded uses of Avast..
04/28 Analyst says there may be more action on Medivation


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions